Aristo Bio-Tech share price
NSE: ARISTOChemicals
Aristo Bio-Tech at a glance
Aristo Bio-Tech (NSE: ARISTO) closed at ₹94.00 on 8 Oct 2026. With a market capitalisation of ₹64 Cr, it ranks 2933rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector.
Its return on equity was 10.9% in FY25. Over the past year the share price has fallen 32.7%. Its 52-week range is ₹74.30 (2 Apr 2026) to ₹136.00 (9 Oct 2025); the last close is 30.9% below the high. Promoters held 73.42% of the company as of 31 Mar 2026.
Key numbers
- Market cap
- ₹64 CrRank 2933 on NSE
- Price to book
- 2.12×FY25
- ROE
- 10.9%FY25
- ROCE
- 15.8%FY25
- Debt to equity
- 0.59FY25
- Net profit margin
- 1.3%FY25
- Book value / share
- ₹54.84FY25
- Dividend payout
- 8.4%FY25
- 52-week high
- ₹136.009 Oct 2025
- 52-week low
- ₹74.302 Apr 2026
- 1-year return
- −32.7%
- RSI (14-day)
- 42.4
Returns to 21 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | 0.00% | −1.1% | −14.6% | +8.9% | −32.7% |
Aristo Bio-Tech financials
| Item | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | ₹218 Cr | ₹245 Cr | ₹318 Cr |
| Operating profit | ₹5 Cr | ₹5 Cr | ₹5 Cr |
| Net profit | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| EPS (₹) | ₹6.72 | ₹5.72 | ₹5.97 |
| Cash from operations | −₹3 Cr | ₹8 Cr | ₹10 Cr |
| Total debt | ₹10 Cr | ₹10 Cr | ₹8 Cr |
| Shareholders' equity | ₹30 Cr | ₹34 Cr | ₹37 Cr |
Aristo Bio-Tech shareholding pattern
| Holder | 30 Sep 2023 | 31 Mar 2024 | 30 Sep 2024 | 31 Mar 2025 | 30 Sep 2025 | 31 Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 73.37% | 73.37% | 73.37% | 73.42% | 73.42% | 73.42% |
| Foreign institutions | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% |
| Domestic institutions | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% |
| Non-institutions | 26.63% | 26.63% | 26.63% | 26.58% | 26.58% | 26.58% |
Aristo Bio-Tech vs peers
The listed Chemicals companies nearest to Aristo Bio-Tech by market capitalisation.
Ask anything about Aristo Bio-Tech
Pivot answers on the live chart with evidence you can check, and tests strategies against ARISTO's own history. Try: “Why has ARISTO moved over the last three months?” · “Backtest a 50-day moving-average crossover on ARISTO over five years” · “Compare ARISTO with BHASKAGR on margins and valuation”
Frequently asked questions about Aristo Bio-Tech
What is the share price of Aristo Bio-Tech today?
Aristo Bio-Tech (NSE: ARISTO) last closed at ₹94.00 on 8 Oct 2026. Its 52-week high is ₹136.00 and its 52-week low is ₹74.30.
What is the market cap of Aristo Bio-Tech?
Aristo Bio-Tech's market capitalisation is ₹64 Cr (₹64 Cr) at the 21 Oct 2026 close, ranking 2933rd among the NSE companies Pivot tracks.
What is the ROE and ROCE of Aristo Bio-Tech?
Return on equity was 10.9% in FY25 and return on capital employed was 15.8% in FY25 (standalone figures).
Is Aristo Bio-Tech a debt-free company?
No. Aristo Bio-Tech's debt-to-equity ratio was 0.59 in FY25, with total debt of ₹8 Cr.
How has Aristo Bio-Tech stock performed over the last year?
Aristo Bio-Tech's share price has fallen 32.7% over the past year, +8.9% over three months and −14.6% over one month, to the 21 Oct 2026 close.
What is the shareholding pattern of Aristo Bio-Tech?
As of 31 Mar 2026: promoters 73.42%, foreign institutions 0.00%, domestic institutions 0.00%, non-institutions 26.58%.
Who are Aristo Bio-Tech's competitors?
The listed Chemicals companies closest to Aristo Bio-Tech by market cap are Bhaskar Agroche, Bhatia Colour, Retina Paints, Teesta Agro Ind, Hardcastle and Yash Chemex.
Is Aristo Bio-Tech a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Aristo Bio-Tech's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ARISTO against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 8 Oct 2026 (returns and ratios at the 21 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Chemicals stocks · companies starting with A · all NSE stocks · this page as text